Contraceptives, Oral

• 

  Subject Areas on Research

  • A mathematical model of tryptophan metabolism via the kynurenine pathway provides insights into the effects of vitamin B-6 deficiency, tryptophan loading, and induction of tryptophan 2,3-dioxygenase on tryptophan metabolites. 
  • A painful swollen arm in a young woman. 
  • Adolescent reproductive events and subsequent breast cancer risk. 
  • Amenorrhea: observations based on the analysis of luteinizing hormone-releasing hormone testing. 
  • Associations of cortisol/testosterone and cortisol/sex hormone-binding globulin ratios with atherosclerosis in middle-age women. 
  • Clinical use of oral contraceptives administered vaginally: a case report. 
  • Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review. 
  • Contraception use, family planning, and unprotected sex: few differences among HIV-infected and uninfected postpartum women in four US states. 
  • Contraceptive Methods and the Impact of Menstruation on Daily Functioning in Women with Sickle Cell Disease. 
  • Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research. 
  • Cycle scheduling with oral contraceptives: Are we compromising rates for convenience? 
  • DNA repair and epidemiology of basal cell carcinoma. 
  • Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy. 
  • Epithelial ovarian cancer risk among women with polycystic ovary syndrome. 
  • Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship. 
  • Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. 
  • Fibrinolytic response and oral contraceptive associated thromboembolism. 
  • Find alternatives for patients using 80 to 100 mcg estrogen OCs. 
  • Hepatic adenoma and focal nodular hyperplasia. 
  • Hepatic adenoma: MR characteristics and correlation with pathologic findings. 
  • Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study. 
  • Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women. 
  • Hypercoagulable states: a review. 
  • In reply. 
  • Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms. 
  • Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status. 
  • Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. 
  • Menopausal hormones and breast cancer in a biracial population. 
  • Microglandular hyperplasia in vaginal adenosis associated with oral contraceptives and prenatal diethylstilbestrol exposure. 
  • No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina. 
  • Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis. 
  • Oral contraceptive pills. Prevention of ovarian cancer and other benefits. 
  • Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. 
  • Oral contraceptive use and risk of cancer--response. 
  • Oral contraceptive use for the primary prevention of ovarian cancer. 
  • Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. 
  • Oral contraceptives and breast cancer among African-american women and white women. 
  • Oral contraceptives and breast cancer: a case-control study with hospital and community controls. 
  • Oral contraceptives and depressive symptomatology: biologic mechanisms. 
  • Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. 
  • Oral contraceptives and survival in breast cancer patients aged 20 to 54 years. 
  • Oral contraceptives and thromboembolic disease. 
  • Oral contraceptives as an over-the-counter medication. 
  • Population distribution of lifetime risk of ovarian cancer in the United States. 
  • Practice bulletin no. 123: thromboembolism in pregnancy. 
  • Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. 
  • Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. 
  • Primary prevention of stroke. 
  • Reducing the risk of oral contraceptive-induced thrombosis. 
  • Reply to: Continuous versus cyclic oral contraceptives for endometriosis: any conclusive evidence? 
  • Reproductive factors and ovarian cancer risk in African-American women. 
  • Reproductive factors in relation to breast cancer characterized by p53 protein expression (United States). 
  • Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation. 
  • Role of hormones including diethylstibestrol (DES) in the pathogenesis of cervical and vaginal intraepithelial neoplasia. 
  • Sex-related differences in clinical drug response: Implications for women's health 
  • Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes. 
  • The metabolism of ethynodiol diacetate by rat and human liver. 
  • Thrombophilia screening in asymptomatic children. 
  • Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part II. What makes a "real" difference? 
  • Vasomotor symptoms, serum estrogens, and gonadotropin levels in surgical menopause. 
  • Venous and arterial thromboembolic disease in women using oral contraceptives. 
  • Von Willebrand factor for menorrhagia: a survey and literature review. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Halabi, Susan, Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Moorman, Patricia Gripka, Professor Emeritus in Family Medicine and Community Health, Duke Cancer Institute